Institute of Tropical Medicine, Antwerp, Belgium.
Trop Med Int Health. 2013 Apr;18(4):403-6. doi: 10.1111/tmi.12073. Epub 2013 Feb 8.
Evidence suggests that human toxocariasis (HT) could stimulate the onset of allergic diseases such as asthma. More specifically, in subjects having a hypothetical 'atopic genotype', HT could boost preexistent allergy symptoms. We tested the latter hypothesis in Cuba, a country where both asthma and HT are prevalent.
In a group of Cuban school-aged children (n = 958), we investigated the association of Toxocara seropositivity and atopic status with asthma. Toxocara seropositivity was diagnosed with ELISA and atopy by allergen skin prick test. Both physician-diagnosed asthma and current wheeze, as determined by International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire, were considered. Associations were assessed using multivariable logistic regression analyses, with either 'physician-diagnosed asthma' or 'current wheeze' as outcome variable.
40.1% of the children were Toxocara seropositive. Prevalences were 21.7% for current wheeze and 32.7% for physician-diagnosed asthma. The odds of having asthma were almost two times higher in atopic children, but only reached borderline significance (OR=1.90, CI 95%: 0.95-3.80 for physician-diagnosed asthma and OR=1.94, CI 95%: 0.98-3.85 for current wheeze). Toxocara seropositivity and physician-diagnosed asthma were associated (OR=1.51, CI 95%: 1.01-2.26). Moreover, in children without antibodies to Toxocara, being atopic was significantly associated with having physician-diagnosed asthma (OR=2.53, CI 95%: 1.63-3.90), while this association was not present in Toxocara positives (OR=1.38, CI 95%: 0.82-2.37).
Our data confirm previous observations of higher Toxocara seropositivity rates in asthmatic children. Toxocara seropositivity appeared to abrogate the apparent association between atopy and asthma in Cuban children. Although this observation was limited to physician-diagnosed asthma, it challenges the hypothesis that HT stimulates the onset of allergic diseases such as asthma in atopic individuals.
有证据表明,人类旋毛虫病(HT)可能会引发哮喘等过敏性疾病。更具体地说,在具有假设的“特应性基因型”的受试者中,HT 可能会加剧先前存在的过敏症状。我们在古巴测试了后一种假设,古巴既是哮喘流行的国家,也是 HT 流行的国家。
在一组古巴学龄儿童(n=958)中,我们研究了 Toxocara 血清阳性和特应性状态与哮喘之间的关联。使用 ELISA 检测 Toxocara 血清阳性,过敏原皮试检测特应性。均通过国际儿童哮喘和过敏研究(ISAAC)问卷考虑医生诊断的哮喘和当前喘息。使用多变量逻辑回归分析评估关联,将“医生诊断的哮喘”或“当前喘息”作为结局变量。
40.1%的儿童 Toxocara 血清阳性。当前喘息的患病率为 21.7%,医生诊断的哮喘为 32.7%。特应性儿童患哮喘的几率几乎是两倍,但仅达到边缘显著(医生诊断的哮喘的 OR=1.90,95%CI:0.95-3.80 和当前喘息的 OR=1.94,95%CI:0.98-3.85)。Toxocara 血清阳性与医生诊断的哮喘有关(OR=1.51,95%CI:1.01-2.26)。此外,在没有 Toxocara 抗体的儿童中,特应性与医生诊断的哮喘显著相关(OR=2.53,95%CI:1.63-3.90),而在 Toxocara 阳性儿童中则没有这种关联(OR=1.38,95%CI:0.82-2.37)。
我们的数据证实了先前观察到的哮喘儿童中 Toxocara 血清阳性率较高的观察结果。Toxocara 血清阳性似乎消除了特应性与古巴儿童哮喘之间的明显关联。尽管这一观察结果仅限于医生诊断的哮喘,但它挑战了 HT 刺激特应性个体发生哮喘等过敏性疾病的假设。